Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteitis fibrosa: treatment trends

C M Headley1

  • 1Nephrology Division, Veteran's Administration Medical Center, Memphis, TN, USA.

ANNA Journal
|April 17, 1998
PubMed
Summary

Renal osteodystrophy, common in end-stage renal disease, involves secondary hyperparathyroidism. Medical management is preferred, with parathyroidectomy reserved for severe or refractory cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced practice nurses: roles in the hemodialysis unit.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association·2000
Same author

Vaginal myeloperoxidase and flora in the pig-tailed macaque.

Journal of medical primatology·2000
Same author

Acquired cystic kidney disease in ESRD.

ANNA journal·2000
Same author

An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization.

The Journal of experimental medicine·1999
Same author

Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB.

The Journal of infectious diseases·1999
Same author

Activation of the human immunodeficiency virus-1 long terminal repeat by respiratory burst oxidants of neutrophils.

Blood·1998

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Renal osteodystrophy is a common complication in patients with end-stage renal disease.
  • Osteitis fibrosa, linked to secondary hyperparathyroidism, is frequently diagnosed.
  • Treatment strategies must be individualized based on disease severity.

Purpose of the Study:

  • To outline current treatment options for renal osteodystrophy.
  • To differentiate between medical and surgical management approaches.
  • To emphasize patient-specific considerations in therapeutic planning.

Main Methods:

  • Review of medical literature on renal osteodystrophy management.
  • Analysis of treatment efficacy for medical interventions.
  • Evaluation of criteria for surgical intervention (parathyroidectomy).

Main Results:

  • Medical management, including calcitriol, dietary changes, and phosphate binders, is the primary treatment for most patients.
  • Parathyroidectomy is indicated for severe, irreversible hyperparathyroidism or treatment failure.
  • Total parathyroidectomy with or without autotransplantation is the standard surgical procedure.

Conclusions:

  • Optimal management of renal osteodystrophy requires a tailored approach.
  • Medical therapy should be the first line of treatment.
  • Surgical intervention is reserved for specific, severe cases of hyperparathyroidism.

Related Experiment Videos